IL238898B - A method for the preparation of human albumin with a reduced level of dissolved oxygen - Google Patents

A method for the preparation of human albumin with a reduced level of dissolved oxygen

Info

Publication number
IL238898B
IL238898B IL238898A IL23889815A IL238898B IL 238898 B IL238898 B IL 238898B IL 238898 A IL238898 A IL 238898A IL 23889815 A IL23889815 A IL 23889815A IL 238898 B IL238898 B IL 238898B
Authority
IL
Israel
Prior art keywords
preparation
dissolved oxygen
human albumin
reduced level
albumin
Prior art date
Application number
IL238898A
Other languages
English (en)
Hebrew (he)
Inventor
Ignacio Jorquera Nieto Juan
Maria Ortiz Fernandez Ana
Costa Rierola Montserrat
Original Assignee
Grifols Sa
Ignacio Jorquera Nieto Juan
Maria Ortiz Fernandez Ana
Costa Rierola Montserrat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52003454&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL238898(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Grifols Sa, Ignacio Jorquera Nieto Juan, Maria Ortiz Fernandez Ana, Costa Rierola Montserrat filed Critical Grifols Sa
Publication of IL238898B publication Critical patent/IL238898B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76—Albumins
    • C07K14/765—Serum albumin, e.g. HSA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL238898A 2014-05-29 2015-05-19 A method for the preparation of human albumin with a reduced level of dissolved oxygen IL238898B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201430824A ES2524516B1 (es) 2014-05-29 2014-05-29 Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido

Publications (1)

Publication Number Publication Date
IL238898B true IL238898B (en) 2018-01-31

Family

ID=52003454

Family Applications (1)

Application Number Title Priority Date Filing Date
IL238898A IL238898B (en) 2014-05-29 2015-05-19 A method for the preparation of human albumin with a reduced level of dissolved oxygen

Country Status (22)

Country Link
US (1) US10350274B2 (enExample)
EP (1) EP2952203B9 (enExample)
JP (3) JP2015224251A (enExample)
KR (1) KR101960729B1 (enExample)
CN (1) CN105315362B (enExample)
AR (1) AR100618A1 (enExample)
AU (1) AU2015202413B2 (enExample)
BR (1) BR102015012091A8 (enExample)
CA (1) CA2890642C (enExample)
CL (1) CL2015001446A1 (enExample)
ES (2) ES2524516B1 (enExample)
HU (1) HUE031823T2 (enExample)
IL (1) IL238898B (enExample)
MX (1) MX362869B (enExample)
MY (1) MY171771A (enExample)
NZ (1) NZ708537A (enExample)
PL (1) PL2952203T3 (enExample)
PT (1) PT2952203T (enExample)
RU (1) RU2657578C2 (enExample)
SG (1) SG10201504137PA (enExample)
TW (1) TWI607018B (enExample)
ZA (1) ZA201503539B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido
ES2900302T3 (es) 2016-04-28 2022-03-16 Alkahest Inc Fracciones de plasma como terapia para el crecimiento y la progresión del tumor
HRP20211628T1 (hr) 2016-08-18 2022-02-04 Alkahest, Inc. Frakcije krvne plazme kao tretman za kongitivne poremećaje povezane sa starenjem
BR112019022402A2 (pt) 2017-04-26 2020-05-19 Alkahest Inc regime de dosagem para tratamento de comprometimentos cognitivo e motor com plasma sanguíneo e produtos de plasma sanguíneo
WO2020018343A1 (en) 2018-07-20 2020-01-23 Alkahest, Inc. Dosing regimen for treatment of cognitive and motor impairments with blood plasma and blood plasma products
MX2021004755A (es) 2018-10-26 2021-06-08 Alkahest Inc Uso de plasma y fracciones de plasma para mejorar el dolor, la cicatrizacion de heridas y la recuperacion posoperatoria.
CN109627322A (zh) * 2019-01-07 2019-04-16 中国科学院过程工程研究所 一种从Cohn组分Ⅴ上清中分离纯化人血清白蛋白的方法
CN114667151B (zh) 2019-11-04 2025-05-23 万能溶剂有限公司 用于肌肉再生的血浆级分
WO2021102032A1 (en) 2019-11-20 2021-05-27 Alkahest, Inc. Blood plasma fractions for use in liver regeneration
WO2024200553A1 (en) 2023-03-29 2024-10-03 Grifols Worldwide Operations Limited COMPOSITIONS AND METHODS OF PREPARATION OF BLOOD PLASMA PRODUCTS WITH REDUCED LEVELS OF FceRIß AUTOANTIBODIES
CN118166053B (zh) * 2024-03-15 2025-02-07 通化安睿特生物制药股份有限公司 一种制备低o-糖基化水平的重组人白蛋白的方法
WO2025230830A1 (en) 2024-04-29 2025-11-06 Alkahest, Inc. Compositions of blood plasma fractions and their use in treatment of spinal muscular atrophy (sma)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
SE9301581D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Protein formulation
JPH07126182A (ja) * 1993-10-27 1995-05-16 Green Cross Corp:The 組換えヒト血清アルブミン製剤の滅菌方法
SE9402119D0 (sv) * 1994-06-16 1994-06-16 Pharmacia Ab Solution
US5766582A (en) * 1994-10-11 1998-06-16 Schering Corporation Stable, aqueous alfa interferon solution formulations
JP4254117B2 (ja) * 2001-03-27 2009-04-15 ニプロ株式会社 アルブミン溶液収容プラスチック容器
DE60234142D1 (de) * 2001-03-27 2009-12-10 Nipro Corp Albuminlösung enthaltender Kunststoffbehälter
WO2003002139A1 (fr) * 2001-06-29 2003-01-09 Asahi Kasei Kabushiki Kaisha Procede permettant d'ameliorer la stabilite de la preparation de proteines
US7252799B2 (en) * 2001-08-31 2007-08-07 Clearant, Inc. Methods for sterilizing preparations containing albumin
ATE342904T1 (de) * 2003-08-28 2006-11-15 Nipro Corp Künstlicher sauerstoffträger und herstellungsverfahren dafür
JP5364382B2 (ja) * 2006-02-07 2013-12-11 シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド 遊離チオール部分を有するタンパク質の安定化された組成物
ES2294976B1 (es) * 2007-11-12 2008-12-16 Grifols, S.A. "procedimiento de obtencion de albumina humana de alta eficacia para su uso en terapia de detoxificacion".
JP5990880B2 (ja) * 2011-08-31 2016-09-14 東レ株式会社 有用タンパク質組成物およびその製造方法
CN102816230B (zh) * 2012-08-27 2014-02-12 同路生物制药股份有限公司 人血白蛋白的制备方法
ES2524516B1 (es) * 2014-05-29 2015-03-31 Grifols Worldwide Operations Limited Procedimiento de preparación de albúmina humana con nivel de oxígeno disuelto reducido

Also Published As

Publication number Publication date
JP2015224251A (ja) 2015-12-14
MY171771A (en) 2019-10-29
TWI607018B (zh) 2017-12-01
AR100618A1 (es) 2016-10-19
CA2890642C (en) 2019-02-12
PT2952203T (pt) 2016-11-23
US20150343025A1 (en) 2015-12-03
CN105315362B (zh) 2019-10-25
EP2952203B1 (en) 2016-10-26
US20170000855A9 (en) 2017-01-05
CL2015001446A1 (es) 2016-05-13
CN105315362A (zh) 2016-02-10
ES2601137T3 (es) 2017-02-14
AU2015202413B2 (en) 2017-08-31
SG10201504137PA (en) 2015-12-30
ZA201503539B (en) 2017-01-25
TW201544510A (zh) 2015-12-01
ES2524516A1 (es) 2014-12-09
CA2890642A1 (en) 2015-11-29
JP2020111614A (ja) 2020-07-27
HUE031823T2 (en) 2017-08-28
BR102015012091A2 (pt) 2016-01-05
JP2018115210A (ja) 2018-07-26
EP2952203B9 (en) 2018-03-14
US10350274B2 (en) 2019-07-16
RU2657578C2 (ru) 2018-06-14
KR101960729B1 (ko) 2019-03-21
BR102015012091A8 (pt) 2021-03-16
RU2015118453A (ru) 2016-12-10
AU2015202413A1 (en) 2015-12-17
NZ708537A (en) 2017-06-30
KR20160024348A (ko) 2016-03-04
EP2952203A1 (en) 2015-12-09
MX362869B (es) 2019-02-20
ES2524516B1 (es) 2015-03-31
MX2015006407A (es) 2015-11-30
PL2952203T3 (pl) 2017-02-28

Similar Documents

Publication Publication Date Title
IL279627A (en) A method for treating depression
SG10201504137PA (en) Method For The Preparation Of Human Albumin With Reduced Level Of Dissolved Oxygen
IL251560A0 (en) Methods for preparing ribosides
IL250070A0 (en) A walk-up chair
SG11201703928QA (en) Patient interface
AU358462S (en) Patient interface
PL3193995T3 (pl) Interfejs do współpracowania z pacjentem
EP3165246A4 (en) Blood circulation system
PL3174988T3 (pl) Sposób wytwarzania kwasu mlekowego
IL248288A0 (en) Device and method for preparing and administering blood components
IL258922A (en) Methods for the preparation of obeticholic acid and derivatives thereof
PT3020430T (pt) Cânula para terapia de implantação de sutura catgut
SG11201702700UA (en) Methods for the treatment of peri-implantitis
EP3106128A4 (en) Artificial blood vessel
GB2519228B (en) Wheelchair
GB2538767B (en) Coffin
IL259073A (en) History of abscisic acid - converted at the 3' position
IL249463A0 (en) Production method for (s)-2-acetyloxypropionic acid and their derivatives
PL3023085T3 (pl) Trumna
TWM532856U (en) Combined coffin structure
EP3181093A4 (en) Artificial blood vessel
ZA201802926B (en) Electrocatalyst for the reduction of oxygen
GB201503737D0 (en) Red funeral hearse
AU359444S (en) Wheelchair antitip part
GB201505487D0 (en) Method for ascertaining the vertical position of tissue structure

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed